Examination Report |
1 | Additional Representation Sheet | 27 Aug 2014 |
1 | Power of Attorney | 27 Aug 2014 |
1 | TM-1 | 27 Aug 2014 |
2 | Power of Attorney | 27 Aug 2014 |
2 | TM-1 | 27 Aug 2014 |
3 | Additional Representation Sheet | 27 Aug 2014 |
3 | TM-1 | 27 Aug 2014 |
4 | Reply to Exam Report (MIS-R) | 25 Apr 2016 |
5 | Journal Copy | 13 Sep 2017 |
6 | Certificate | 28 Sep 2017 |
7 | TM-R(RENEWAL WITH SURCHARGE) | 30 Aug 2024 |
1 | Dispatching of Examination Report for : 2798691 | 3426030 | 1786997 | 01 Apr 2016 |
2 | O3 NOTICE | 18451906 | 6810122 | 05 Jul 2024 |
3 | RENEWAL INTIMATION LETTER | 18792340 | 02 Sep 2024 |
The application for Creofine was made on 27 August 2014.
The trademark applicant for Creofine is MACLEODS PHARMACEUTICALS.
Creofine is applied in class(es) 5.
Application for Creofine is on Registered stage.
Application Id allotted to Creofine is 2798691.
Creofine filed with the Intellectual property office as a DEVICE.